What is Hexaxim?
â A new, unique, fully liquid, 6 in 1 pediatric vaccine, combining a new Sanofi Pasteur recombinant hepatitis B antigen produced in Hansenula polymorpha with five well established antigens manufactured by Sanofi Pasteur and extensively used worldwide since 1997 as Tetravac/Tetraxim (DTaP-IPV) and Pentavac/Pentaxim (DTaPIPV//Hib)
â For primary and booster vaccination of infants and toddlers from 6 weeks to 24 months of age against six WHO priority diseases: diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, invasive diseases caused by Haemophilus influenza type b
â To respond to unmet medical needs and improve the standard of care in lower-middle income countries, Sanofi Pasteur prioritized the development of Hexaxim for emerging countries
Why not download the full presentation to get all the details on Hexaxim: paediatric hexavalent fully liquid vaccine for international countries
Â· Article 58 lessons learned
Dr Sandrine Lentsch Graf, Project Leader, sanofi pasteur
To learn more about this and the other topics discussed at the World Vaccine Congress Lyon, please click here >